Menu
 
Research menu
Jump to menu

Publications:  Dr Kate Moore

Moore KM, Desai A, de Luxán Delgado B, Trabulo SMD, Reader C, Brown NF, Murray ER, Brentnall A et al.(2020). Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus. Theranostics vol. 10, (7) 2930-2942.
10.7150/thno.38702
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64292
Reader CS, Vallath S, Steele CW, Haider S, Brentnall A, Desai A, Moore KM, Jamieson NB et al.(2019). The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. Journal of Pathology vol. 249, (3) 332-342.
10.1002/path.5320
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58426
Thomas JR, Moore KM, Sproat C, Mo S, Wolanska KI, Maldonado H, Haider S, Newman D et al. (2019). Integrin alpha V beta 6-EGFR crosstalk regulates bidirectional force transmission and controls breast cancer invasion. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. vol. 100, A39-A39.
Caley M, Martins V, Moore K, Lashari M, Marshall J, O'Toole E (2018). Loss of Lam alpha 3 drives M2 macrophage differentiation in squamous cell carcinoma. BRITISH JOURNAL OF DERMATOLOGY. vol. 178, E399-E400.
Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker AM, Kapitonova E, Bakhouche BA, Tanner Y et al.(2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Reports vol. 22, (9) 2469-2481.
10.1016/j.celrep.2018.02.028
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56422
Caley M, Martins V, Moore K, Lashari M, Marshall J, O'Toole EA (2017). Tumour associated macrophage recruitment in SCC. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 137, S250-S250.
10.1016/j.jid.2017.07.531
https://qmro.qmul.ac.uk/xmlui/handle/123456789/61726
Caley M, Martins V, Moore K, Lashari M, Kahari V, Nissinen L, Donaldson M, Marshall J et al. (2016). Loss of Laminin alpha 3 drives SCC invasion via ROCK signalling. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 136, S241-S241.
10.1016/j.jid.2016.06.494
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59408
Caley M, Martins V, Moore K, Lashari M, Donaldson M, Marshall JF, O'Toole EA (2016). ROCK and Rac1 signalling in squamous cell carcinoma with loss of laminin 332. BRITISH JOURNAL OF DERMATOLOGY. vol. 174, E51-E51.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63939
Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M et al.(2015). Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC. J Natl Cancer Inst vol. 108, (1)
10.1093/jnci/djv293
https://qmro.qmul.ac.uk/xmlui/handle/123456789/29087
Martins V, Caley M, Moore K, Szentpetery Z, Marsh S, Murrell DF, Kaehaeri V, McGrath J et al. (2015). Skin type VII collagen acts as a tumour suppressor by regulating TGF beta and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 135, S28-S28.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10961
Caley M, Martins V, Marsh S, Moore K, Lashari M, Donaldson MJ, Marshall J, O'toole E (2015). Squamous Cell Carcinoma progression and Laminin 332. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 135, S23-S23.
Caley M, Martins V, Moore K, Marshall J, O'toole E (2014). Diverse roles for laminin 332 subunits in squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 134, S19-S19.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2014). Therapeutic targeting of integrin αvβ6 in breast cancer. J Natl Cancer Inst vol. 106, (8)
10.1093/jnci/dju169
https://qmro.qmul.ac.uk/xmlui/handle/123456789/8829
Caley M, Martins V, Moore K, Marshall J, O'Toole E (2014). Diverse roles for laminin-332 subunits in squamous cell carcinoma. BRITISH JOURNAL OF DERMATOLOGY. vol. 170, E26-E26.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2013). Integrin avb6 is a therapeutic target for high-risk breast cancer and enhances trastuzumab efficacy. CANCER RESEARCH vol. 73,
10.1158/0008-5472.SABCS13-P4-15-01
Gordon-Keylock S, Sobiesiak M, Rybtsov S, Moore K, Medvinsky A(2013). Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs. BLOOD vol. 122, (14) 2338-2345.
10.1182/blood-2012-12-470971
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2013). Therapeutic targeting of integrin alpha v beta 6 in high-risk breast cancer. MOLECULAR CANCER RESEARCH vol. 11,
10.1158/1557-3125.ADVBC-B046
Caley MP, Martins V, Moore K, Marshall JF, O'Toole EA (2013). Diverse roles for laminin 332 subunits in squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 133, S64-S64.
Martins VL, Caley MP, Moore K, Szentpetery Z, Murrell DF, Kim MH, McGrath JA, Cerio R et al. (2013). Loss of type VII collagen in cutaneous SCC increases angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 133, S158-S158.
Martins V, Caley M, Moore K, Murrell DF, McGrath JA, Chen M, Marshall JF, O'Toole EA (2012). Loss of keratinocyte type VII collagen in SCC increases TGF-beta signalling and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 132, S45-S45.
Martins V, Caley M, Moore K, Chen M, Marshall J, O'Toole E (2012). Loss of type VII collagen in squamous cell carcinoma increases angiogenesis in vitro and in vivo. BRITISH JOURNAL OF DERMATOLOGY. vol. 166, e25-e26.
Moore KM, Hart IR, Jones LJ, Marshall JF(2011). Integrin avb6 Mediates HER2-Driven Invasion in Breast Cancer. CANCER RESEARCH vol. 71,
10.1158/0008-5472.SABCS11-P2-01-05
Martins VL, Moore K, Chen M, Marshall J, O'Toole EA (2011). Loss of type VII collagen in SCC leads to increased invasion and TGF-beta signalling in vivo. BRITISH JOURNAL OF DERMATOLOGY. vol. 164, 910-910.
Martins V, Moore K, Chen M, Marshall J, O'Toole EA (2011). Loss of type VII collagen in squamous cell carcinoma leads to increased invasion and TGF-beta signalling in vivo. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 131, S33-S33.
Return to top